Accro Bioscience has developed a robust pipeline focusing on autoimmune, inflammatory, fibrotic diseases and cancer.
| Pipeline | Indication | Discovery | Pre-Clinical | IND | Phase 1 | Phase 2 |
|---|---|---|---|---|---|---|
| IPF | ||||||
AC-003 | GvHD | |||||
| Rheumatoid Arthritis | ||||||
| Ulcerative Colitis | ||||||
AC-101 | IBD | |||||
| Anti-inflammation | ||||||
AC-201 | Psoriasis | |||||
| SLE | ||||||
AC-203 | Rheumatoid Arthritis | |||||
| AS,HS,AD,AA,SLE | ||||||
| DLBCL | ||||||
AC-301 | Leukemia | |||||
| Anti-inflammation |
